Preview

Neurology, Neuropsychiatry, Psychosomatics

Advanced search

Anxiety: phenomenology, epidemiology, and risk factors during the novel coronavirus SARS-CoV-2 (COVID-19) pandemic

https://doi.org/10.14412/2074-2711-2021-1-107-112

Full Text:

Abstract

The COVID-19 coronavirus pandemic in 2020 led to significant negative social consequences associated inter alia with adverse effects on mental health. One of the most common mental illness is anxiety disorders, the rise in which is characteristic of social upheaval periods. This paper analyzes the problem of anxiety, reviews information on the epidemiology of anxiety, on the factors and mechanisms of its development. It unveils the association of anxiety with addictive disorders, lifestyle factors, and traumatic childhood experience and highlights the problem of increased anxiety in the context of the novel coronavirus COVID-19 pandemics in Russia.

About the Authors

A. G. Merkin
Federal Research and Clinical Center of Specialized Types of Medical Care and Medical Technologies, Federal Biomedical Agency of Russia; Centre for Precise Psychiatry and Neurosciences
Russian Federation

Aleksander Gennadievich Merkin

Academy for Postgraduate Training

91, Volokolamskoe Shosse, Moscow 125371
Hennersdorfer Weg 3, 87600 Kaufbeuren, Germany 



S. S. Akinfieva
Doverie (Trust) National Center for Social Support and Rehabilitation Technologies
Russian Federation
10, Likhov Lane, Moscow 127051


A. V. Martyushev-Poklad
Federal Research and Clinical Center for Resuscitation and Rehabilitation
Russian Federation
777, Lytkino Village, Solnechnogorsky District, Moscow Region 141534


O. P. Beloskurskaya
Peoples' Friendship University of Russia (RUDN University)
Russian Federation

Institute for Advanced Training and Retraining of Personnel

10, Miklukho-Maklai St., Build. 2, Moscow 117198



E. N. Dinov
Peoples' Friendship University of Russia (RUDN University)
Russian Federation

Institute for Advanced Training and Retraining of Personnel

10, Miklukho-Maklai St., Build. 2, Moscow 117198



S. L. Ostrovsky
Peoples' Friendship University of Russia (RUDN University)
Russian Federation

Institute for Advanced Training and Retraining of Personnel

10, Miklukho-Maklai St., Build. 2, Moscow 117198



A. N. Komarov
Doverie (Trust) National Center for Social Support and Rehabilitation Technologies
Russian Federation
10, Likhov Lane, Moscow 127051


O. Yu. Zakharova
Russian Presidential Academy of National Economy and Public Administration
Russian Federation

Institute of Social Sciences

82, Vernadsky Prospect, Build. 1, Moscow 119571



V. A. Kazhin
Centre for Precise Psychiatry and Neurosciences
Germany
Hennersdorfer Weg 3, 87600 Kaufbeuren


I. A. Nikiforov
Federal Research and Clinical Center of Specialized Types of Medical Care and Medical Technologies, Federal Biomedical Agency of Russia
Russian Federation

Academy for Postgraduate Training

91, Volokolamskoe Shosse, Moscow 125371



M. Glover
Centre of Research Excellence: Indigenous Sovereignty & Smoking
New Zealand
PO Box 89186, Torbay, Auckland 0742


References

1. Brooks SK, Webster RK, Smith LE, et al. The psychological impact of quarantine and how to reduce it: rapid review of the evidence. Lancet. 2020 Mar 14;395(10227):912-20. doi: 10.1016/S0140-6736(20)30460-8. Epub 2020 Feb 26.

2. Baxter AJ, Scott KM, Vos T, et al. Global prevalence of anxiety disorders: a systematic review and meta-regression. Psychol Med. 2013 May;43(5):897-910. doi: 10.1017/S003329171200147X. Epub 2012 Jul 10.

3. Apchel VYa, Tsygan VN. Stress i stressoustoychivost' cheloveka [Human stress and resistance to stress]. St. Petersburg: Piter; 1999. 86 p. (In Russ.).

4. De Kloet ER, Joels M, Holsboer F. Stress and the brain: from adaptation to disease. Nat Rev Neurosci. 2005 Jun;6(6):463-75. doi: 10.1038/nrn1683

5. American Psychiatric Association. Diagnostic and Statistical manual of mental disorders, 5 th ed. (DSM-V). American Psychiatric Publishing; 2013. 991 p.

6. Spielberger CD, Gorsuch RL, Lushene RD, et al. Consulating Psychol. Manual for the State-Trait Anxiety Inventory (STAI). CA: Consulting Psychologists Press; 1983.

7. Solov'yeva SL. Anxiety and anxiety: theory and practice. Meditsinskaya psikhologiya v Rossii. 2012;(6):14 (In Russ.).

8. Sylvers P, Lilienfeld SO, LaPrairie JL. Differences between trait fear and trait anxiety: Implications for psychopathology. Clin Psychol Rev. 2011 Feb;31(1):122-37. doi: 10.1016/j.cpr.2010.08.004. Epub 2010 Aug 14.

9. Spielberger BH. Conceptual and methodological problems of anxiety research. In: Khanin Yu, compiler. Stress i trevoga v sporte [Stress and anxiety in sports]. Moscow: Fizkul'tura i sport; 1983. P. 12-24 (In Russ.).

10. Prikhozhan AM. Trevozhnost' u detey i podrostkov: psikhologicheskaya priroda i vozrastnaya dinamika [Anxiety in children and adolescents: psychological nature and age dynamics]. Moscow; 2000 (In Russ.).

11. Taylor J (adaptation by Nemchin TA). Personal scale of manifestations of anxiety. In: Dermanova IB, editor and compiler. Diagnostika emotsional'no-nravstvennogo razvitiya [Diagnostics of emotional and moral development]. St. Petersburg; 2002. P. 126 (In Russ.).

12. Spielberger CD (adaptation by Hanin YuL). Research on anxiety. In: Dermanova IB, editor and compiler. Diagnostika emotsional'nonravstvennogo razvitiya [Diagnostics of emotional and moral development]. St. Petersburg; 2002. P. 124-6 (In Russ.).

13. GAD-7 Questionnaire (GAD-7) and WFSBP Recommendations for the Treatment of Generalized Anxiety Disorder. Obozreniye psikhiatrii i meditsinskoy psikhologii. 2013;(2):71 (In Russ.).

14. Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand. 1983 Jun;67(6):361-70. doi: 10.1111/j.16000447.1983.tb09716.x

15. Prikhozhan AM. Psikhologiya trevozhnosti: doshkol'nyy i shkol'nyy vozrast [Psychology of anxiety: preschool and school age]. St. Petersburg; 2009. 192 p. ISBN 978-5-46901499-7 (In Russ.).

16. Shal'nova SA, Yevstifeyeva SE, Deyev AD, et al. Prevalence of anxiety and depression in various regions of the Russian Federation and its association with socio-demographic factors (according to the ESSE-RF study). Terapevticheskiy arkhiv = Therapeutic Archive. 2014;86(12):53-60. doi: 10.17116/terarkh2014861253-60 (In Russ.).

17. Songtachalert T, Roomruangwong C, Carvalho AF, et al. Anxiety disorders: sex differences in serotonin and tryptophan metabolism. Curr Top Med Chem. 2018;18(19):1704-15. doi: 10.2174/1568026618666181115093136

18. Gafarov VV, Gromova EA, Panov DO, et al. Prevalence of personal anxiety and attitude to their health among women – residents of a large industrial center. Arkhiv vnutrenney meditsiny. 2012;(3):42-7. doi: 10.20514/22266704-2012-0-3-42-47 (In Russ.).

19. Gafarov VV, Gagulin IV, Gafarova AV, et al. Psychosocial risk factors for cardiovascular disease: gender differences and 22-year dynamics among the population of Siberia (WHO MONICA-Psychosocial Program, HAPIEE). Terapevticheskiy arkhiv = Therapeutic Archive. 2020;92(1):15-24. doi: 10.26442/00403660.2020.01.000249 (In Russ.).

20. Smirnov AV. Bazovyye psikhologicheskiye komponenty addiktivnogo povedeniya v strukture integral'noy individual'nosti [Basic psychological components of addictive behavior in the structure of the integral personality]. Moscow: Tsentrpoligraf; 2015. P. 134 (In Russ.).

21. Martyushev-Poklad AV, Voronina TA. Stresslimiting systems and neuronal plasticity in the pathogenesis of mental and neurological disorders.. Obzory po klinicheskoy farmakologii i lekarstvennoy terapii. 2003;2(4):15-25 (In Russ.).

22. Zorrilla EP, Logrip ML, Koob GF. Corticotropin releasing factor: a key role in the neurobiology of addiction. Front Neuroendocrinol. 2014 Apr;35(2):234-44. doi: 10.1016/j.yfrne.2014.01.001. Epub 2014 Jan 20.

23. Jacques A, Chaaya N, Beecher K, et al. The impact of sugar consumption on stress driven, emotional and addictive behaviors. Neurosci Biobehav Rev. 2019 Aug;103:178-99. doi: 10.1016/j.neubiorev.2019.05.021. Epub 2019 May 21.

24. Ventura T, Santander J, Torres R, et al. Neurobiologic basis of craving for carbohydrates. Nutrition. 2014 Mar;30(3):252-6. doi: 10.1016/j.nut.2013.06.010. Epub 2013 Oct 17.

25. Parylak SL, Koob GF, Zorrilla EP. The dark side of food addiction. Physiol Behav. 2011 Jul 25;104(1):149-56. doi: 10.1016/j.physbeh.2011.04.063. Epub 2011 May 8.

26. Moonat S, Pandey SC. Stress, epigenetics, and alcoholism. Alcohol Res. 2012;34(4):495-505.

27. Becker HC. Influence of stress associated with chronic alcohol exposure on drinking. Neuropharmacology. 2017 Aug 1;122:115-26. doi: 10.1016/j.neuropharm.2017.04.028. Epub 2017 Apr 19.

28. Han B, Zhu FX, Yu HF, et al. Low serum levels of vitamin D are associated with anxiety in children and adolescents with dialysis. Sci Rep. 2018 Apr 13;8(1):5956. doi: 10.1038/s41598-018-24451-7

29. Anglin RE, Samaan Z, Walter SD, et al. Vitamin D deficiency and depression in adults: systematic review and meta-analysis. Brit J Psychiatry. 2013 Feb;202:100-7. doi: 10.1192/bjp.bp.111.106666

30. Casseb GA, Kaster MP, Rodrigues ALS. Potential role of vitamin D for the management of depression and anxiety. CNS Drugs. 2019 Jul;33(7):619-37. doi: 10.1007/s40263-01900640-4

31. Thesing CS, Bot M, Milaneschi Y, et al. Omega-3 polyunsaturated fatty acid levels and dysregulations in biological stress systems. Psychoneuroendocrinology. 2018 Nov;97:206-15. doi: 10.1016/j.psyneuen.2018.07.002. Epub 2018 Jul 8.

32. Petry NM, Barry D, Pietrzak RH, et al. Overweight and obesity are associated with psychiatric disorders: results from the National Epidemiologic Survey on Alcohol and Related Conditions. Psychosomat Med. 2008;70(3):288-97. doi: 10.1097/PSY.0b013e3181651651

33. Häuser W, Janke K-H, Klump B, Hinz A. Anxiety and depression in patients with inflammatory bowel disease: comparisons with chronic liver disease patients and the general population. Inflamm Bowel Dis. 2011 Feb;17(2):621-32. doi: 10.1002/ibd.21346

34. Lee S, Wu J, Ma YL, et al. Irritable bowel syndrome is strongly associated with generalized anxiety disorder: a community study. Aliment Pharmacol Ther. 2009 Sep 15;30(6):643-51. doi: 10.1111/j.1365-2036.2009.04074.x. Epub 2009 Jun 23.

35. Graff LA, Walker JR, Bernstein CN. Depression and anxiety in inflammatory bowel disease: a review of comorbidity and management. Inflamm Bowel Dis. 2009 Jul;15(7):1105-18. doi: 10.1002/ibd.20873

36. Kurina L, Goldacre MJ, Yeates D, et al. Depression and anxiety in people with inflammatory bowel disease. J Epidemiol Community Health. 2001 Oct;55(10):716-20. doi: 10.1136/jech.55.10.716

37. Taylor AM, Thompson SV, Edwards CG, et al. Associations among diet, the gastrointestinal microbiota, and negative emotional states in adults. Nutr Neurosci. 2020 Dec;23(12):983-92. doi: 10.1080/1028415X.2019.1582578. Epub 2019 Feb 22.

38. Paiva IHR, Duarte-Silva E, Peixoto CA. The role of prebiotics in cognition, anxiety, and depression. Eur Neuropsychopharmacol. 2020 May;34:1-18. doi: 10.1016/j.euroneuro.2020.03.006. Epub 2020 Mar 30.

39. Ansari F, Pourjafar H, Tabrizi A, et al. The effects of probiotics and prebiotics on mental disorders: a review on depression, anxiety, Alzheimer, and autism spectrum disorders. Curr Pharm Biotechnol. 2020;21(7):555-65. doi: 10.2174/1389201021666200107113812

40. Kandola A, Vancampfort D, Herring M, et al. Moving to beat anxiety: Epidemiology and therapeutic issues with physical activity for anxiety. Curr Psychiatry Rep. 2018 Jul 24;20(8):63. doi: 10.1007/s11920-018-0923-x

41. Paluska SA, Schwenk TL. Physical activity and mental health. current concepts. Sports Med. 2000 Mar;29(3):167-80. doi: 10.2165/00007256-200029030-00003

42. Kelly P, Williamson C, Niven AG, et al. Walking on sunshine: scoping review of the evidence for walking and mental health. Brit J Sports Med. 2018 Jun;52(12):800-6. doi: 10.1136/bjsports-2017-098827

43. Petrova EA. Impact of children traumatic experience on the formation of psychopathology of adults. Vestnik Novgorodskogo gosudarstvennogo universiteta im. Yaroslava Mudrogo. 2016;2(93):88-91 (In Russ.).

44. Kuo JR, Goldin PR, Werner K, et al. Childhood trauma and current psychological functioning in adults with social anxiety disorder. J Anxiety Disord. 2011 May;25(4):467-73. doi: 10.1016/j.janxdis.2010.11.011. Epub 2010 Nov 26.

45. Felitti VJ, Anda RF, Nordenberg D, et al. Relationship of childhood abuse and household dysfunction to many of the leading causes of death in adults: The Adverse Childhood Experiences (ACE) Study. Am J Prevent Med. 1998 May;14(4):245-58. doi: 10.1016/s07493797(98)00017-8

46. Parohan M, Yaghoubi S, Seraji A, et al. Risk factors for mortality in patients with Coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies. Aging Male. 2020 Jun 8;1-9. doi: 10.1080/13685538.2020.1774748. Online ahead of print.

47. Folkman S, Lazarus RS. Manual for the ways of coping questionnaire: Research edition. Palo Alto, CA: Consulting Psychologists Press; 1988.

48. Weber H. Breaking the rules: Personal and social responses to coping norm-violations. Anxiety Stress Coping. 2003;16(2):133-53. doi: 10.1080/1061580031000120174

49. Bäuerle A, Teufel M, Musche V, et al. Increased generalized anxiety, depression and distress during the COVID-19 pandemic: a cross-sectional study in Germany. J Pub Health. 2020 Nov 23;42(4):672-8. doi: 10.1093/pubmed/fdaa106

50. Yao H, Chen JH, Xu YF. Patients with mental health disorders in the COVID-19 epidemic. Lancet Psychiatry. 2020 Apr;7(4):e21. doi: 10.1016/S2215-0366(20)30090-0

51. Pappa S, Ntella T, Giannakas T, et al. Prevalence of depression, anxiety, and insomnia among healthcare workers during the COVID-19 pandemic: A systematic review and meta-analysis. Brain Behav Immun. 2020 Aug;88:901-7. doi: 10.1016/j.bbi.2020.05.026. Epub 2020 May 8.

52. Asmundson GJ, Taylor S. How health anxiety influences responses to viral outbreaks like COVID-19: What all decision-makers, health authorities, and health care professionals need to know. J Anxiety Disord. 2020 Apr;71:102211. doi: 10.1016/j.janxdis.2020.102211. Epub 2020 Mar 10.

53. Mazza MG, Lorenzo RD, Conte C, et al. Anxiety and depression in COVID-19 survivors: Role of inflammatory and clinical predictors. Brain Behav Immun. 2020 Oct;89:594-600. doi: 10.1016/j.bbi.2020.07.037. Epub 2020 Jul 30.

54. Fullana MA, Hidalgo-Mazzei D, Vieta E, et al. Coping behaviors associated with decreased anxiety and depressive symptoms during the COVID-19 pandemic and lockdown. J Affect Dis. 2020 Oct 1;275:80-1. doi: 10.1016/j.jad.2020.06.027. Epub 2020 Jul 2.

55. Vollestad J, Sivertsen B, Nielsen GH. Mindfulness-based stress reduction for patients with anxiety disorders: Evaluation in a randomized controlled trial. Behav Res Ther. 2011 Apr;49(4):281-8. doi: 10.1016/j.brat.2011.01.007. Epub 2011 Jan 27.

56. Liu K, Chen Y, Wu D, et al. Effects of progressive muscle relaxation on anxiety and sleep quality in patients with COVID-19. Complement Ther Clin Pract. 2020 May;39:101132. doi: 10.1016/j.ctcp.2020.101132. Epub 2020 Mar 6.


For citation:


Merkin A.G., Akinfieva S.S., Martyushev-Poklad A.V., Beloskurskaya O.P., Dinov E.N., Ostrovsky S.L., Komarov A.N., Zakharova O.Yu., Kazhin V.A., Nikiforov I.A., Glover M. Anxiety: phenomenology, epidemiology, and risk factors during the novel coronavirus SARS-CoV-2 (COVID-19) pandemic. Neurology, Neuropsychiatry, Psychosomatics. 2021;13(1):107-112. (In Russ.) https://doi.org/10.14412/2074-2711-2021-1-107-112

Views: 451


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 2074-2711 (Print)
ISSN 2310-1342 (Online)